In-silico testing of Novel Steroidal Derivatives as FGFR1 Agonists for Enhanced Regeneration in Adult Tissues
RADS Journal of Biological Research & Applied Sciences · 05.08.2026 · 17 (1)
DOI: 10.37962/jbas.v17i1.695 ↗Kurz gefasst
Fachartikel in der Zeitschrift RADS Journal of Biological Research & Applied Sciences, online erschienen am 05.08.2026. Verfasst von Komal Mahmood. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Fibroblast Growth Factors (FGFs) are a crucial superfamily of morphogenic proteins that play a critical role in embryonic development and tissue restoration. They are heavily implicated in wound healing. FGFR1 activation is key toward blastema tissue mediated regeneration. However, sustaining FGFR signals in mammalian tissues is limited. This study aims to design novel steroidal analogs to enhance agonistic dosing of FGFR1 and prolong morphogenetic signaling to potentially enhance regeneration.
Objective
The key objective of this study was the insilico design and evaluation of FGFR1 steroidal agonists via molecular docking and dynamics simulations. This is to identify candidates that could sustain regenerative signaling. Hypothesis: We hypothesized that novel steroidal analogs for FGFR1 could function as small molecule potentiators of the protein to prolong the sustained activation of FGF in adult mammalian tissues (specifically humans).
Method
Four steroid-based analogs (R1-R4) were computationally designed in a manner to minimize energy. These were docked to the tyrosine kinase domain of the FGFR1 (PDB ID: 1AGW) using AutoDock 4.2.6 prioritizing blind docking over site-specific docking. Docking interactions were evaluated using the online PLIP (Protein0Ligand Interaction Profiler) and using MMFF94 force fields for a molecular dynamics simulation.
Result
R1 with its binding pose 5 exhibited favorable interactions against the protein of interest at -9.36 kJ/mol. This outperformed R3, R2, and R4 to maintain RMSD values of under 2.0 Å indicating stability.
Conclusion
R1 analog should be developed for wet lab evaluation and assessment of pharmacological properties.
Zitieren
APA
Mahmood, K. (2026). In-silico testing of Novel Steroidal Derivatives as FGFR1 Agonists for Enhanced Regeneration in Adult Tissues. RADS Journal of Biological Research & Applied Sciences, 17(1). https://doi.org/10.37962/jbas.v17i1.695
Vancouver
Mahmood K. In-silico testing of Novel Steroidal Derivatives as FGFR1 Agonists for Enhanced Regeneration in Adult Tissues. RADS Journal of Biological Research & Applied Sciences. 2026;17(1). doi:10.37962/jbas.v17i1.695
BibTeX
@article{Mahmood2026,
author = {Mahmood, Komal},
title = {In-silico testing of Novel Steroidal Derivatives as FGFR1 Agonists for Enhanced Regeneration in Adult Tissues},
journal = {RADS Journal of Biological Research & Applied Sciences},
year = {2026},
volume = {17},
number = {1},
doi = {10.37962/jbas.v17i1.695}
}
EUVIMED